SELECTED PROCEEDINGS
Plenaries
Dental Track
Laboratory Track
Medical Track
Musculoskeletal Track
Multidisciplinary Track
PLENARIES
CORNERSTONE OF GLOBAL DEVELOPMENT: 45 YEARS OF PROGRESS
Speaker: Mark Skinner, WFH President
Slides
Video
THE ROLE OF SYNOVECTOMY IN THE MANAGEMENT OF A TARGET JOINT
Speaker: Adolfo Llinas, Colombia
Summary Report
Slides
QUALITY OF LIFE IN HEMOPHILIA
Speaker: Alessandro Gringeri, Italy
Summary Report
ETHICAL CONSIDERATIONS IN CLINICAL INVESTIGATION
Speaker: Donna DiMichele, U.S.A.
Summary Report
HOW TO GET RID OF INHIBITORS
Speaker: Jean-M. Saint-Rémy, Belgium
Summary Report
Slides
ANIMAL MODELS OF BLEEDING AND TISSUE REPAIR
Speaker: Maureane Hoffman, U.S.A.
Summary Report
ADVANCES IN THE MANAGEMENT OF VIRAL HEPATITIS
Speaker: Harvey Alter, U.S.A.
Summary Report
Slides
BACK TO THE FUTURE: A HISTORY OF THE TREATMENT OF HEMOPHILIA
Speaker: Pier Mannucci, Italy
Slides
Video
DENTAL TRACK
MEET THE EXPERTS: MANAGEMENT OF TRAUMA (B1.6)
Chair: Eduardo Rey, Argentina
Summary Report
Panelists: Antonio Valiente Alvarez, Spain, and Wellington Cavalcanti, Brazil
LABORATORY TRACK
NEW APPROACHES IN THE MEASUREMENT OF COAGULATION (C2.6)
Chair: Jorgen Ingerslev, Denmark
Summary Report
Dynamic Evaluation of the Clotting Process in the Hemorrhagic Disorders
Benny Sorensen, Denmark
Laboratory Measurements for the Choice and Monitoring of Treatment in VWD
Giancarlo Castaman, Italy
Mild Hemophilia with Normal Results: Is It a Lab Phenomenon or a Local Issue?
John Lloyd, Australia
Slides
The Impact of the Cone and Plate(let) Analyzer
David Varon, Israel
MEDICAL TRACK
PROPHYLAXIS FOR SEVERE HEMOPHILIA: CLINICAL CHALLENGES IN THE ABSENCE AS WELL AS IN THE PRESENCE OF INHIBITORS (A1.1)
Chair: Victor Blanchette, Canada
Summary Report
Current Status of Factor Prophylaxis in the Hemophilia Population
Victor Blanchette, Canada
Prophylaxis in Patients with Inhibitors
Leonard Valentino, U.S.A.
Prophylaxis for Severe Hemophilia: Challenges for the First, Second and Third Decade of Life
Kathelijn Fischer, The Netherlands
PROGRESS IN THE MOLECULAR BIOLOGY OF INHERITED BLEEDING DISORDERS (B1.1)
Chair: David Lillicrap, Canada
Summary Report
Overview
David Lillicrap, Canada
Coagulation Proteins with Enhanced Biological Properties
Steven Pipe, United Kingdom
Bringing Hemophilia Gene Therapy to the Clinic
Kathy High, U.S.A.
Slides
Engineered Liver Cells for the Treatment of Hemophilia
Kazuo Ohashi, Japan
Cell-Based Strategies for Inherited Protein Deficiencies
Ali Ugur Ural, Turkey
Slides
INFECTIOUS DISEASES (C1.1)
Chair: Jorge Daruich, Argentina
Summary Report
HIV / HCV Co-Infection in Hemophilia
Jorge Daruich, Argentina
The Natural and Unnatural History of Hepatitis C Infection
Harvey Alter, U.S.A.
25 Years of HIV Research: What We Have Learned and What We Still Need to Know
Lucy Dorrell, United Kingdom
Variant Creutzfeldt-Jakob Disease: Transmission by Clotting Factor
James Ironside, United Kingdom
MUSCULOSKELETAL TRACK
INTERNATIONAL PROPHYLAXIS STUDY GROUP FINAL REPORT (D1.1)
Chair: Victor Blanchette, Canada
Summary Report
Overview of the International Prophylaxis Study Group
Victor Blanchette, Canada
Hemophilia Joint Health Score
Brian Feldman, Canada, and Sharon Funk, U.S.A.
Role of MRI for Detection of Early Arthropathy: A Proposed New International MRI Score
Bjorn Lundin, Sweden, and Andrea Doria, Canada
Slides (Lundin)
Slides (Doria)
MULTIDISCIPLINARY TRACK
VON WILLEBRAND DISEASE: ISSUES FOR WOMEN AND MEN (A1.4)
Chair: Ann-Marie Nazzaro, U.S.A.
Summary Report
VWD in Women: Presentation and Identification
Rezan Kadir, United Kingdom
VWD and VWD Prophylaxis Network: A New Treatment Concept
Thomas Abshire, U.S.A.
QoL for Patients with VWD: Nursing Perspective
Lara Oyesiku, United Kingdom
Patient Perspective
Martyn Cooper, United Kingdom
QoL for Patient with VWD: Psychosocial Perspective
Sylvia von Mackensen, Germany
Reproductive Concerns and VWD
Andra James, U.S.A.
Slides
SHARING A HARD LIFE: HOW HEMOPHILIA AFFECTS THE FAMILY (A2.4)
Chair: Ann Duffy, Ireland
Summary Report
Father’s Perspective
Aris Hashim, Malaysia
Mother’s Perspective
Haydee Benoit de García, Dominican Republic
Patient Perspective
Robert Lamberth, Australia
Healthcare Provider Perspective
Elizabeth Fung, United Kingdom
HOW ELDERLY PEOPLE WITH BLEEDING DISORDERS MANAGE THEIR CONDITION (C1.5)
Chair: June Ward, United Kingdom
Summary Report
Impact of Hemophilia on Everyday Life of Elderly Patients
Sylvia von Mackensen, Germany
Physiotherapy and the Hemophilia “Old Boys”
Ethelwym Remmers, South Africa
Slides
Multidisciplinary Approach of the Elderly Hemophilia Patient
Els Haan, The Netherlands
INNOVATIONS IN FACTOR THERAPIES FOR PEOPLE WITH BLEEDING DISORDERS (D1.2)
Chair: David Page, Canada
Summary Report
Solvent-Detergent Treatment of Mini-Pool Cryoprecipitate at Local Blood Centres
Magdy El-Ekiaby, Egypt
The Prospects for Longer-Lasting and Less Immunogenic Factor VIII and IX Concentrates
Paul Giangrande, United Kingdom
The Prospects for Gene Therapy in the Treatment of Bleeding Disorders
David Lillicrap, Canada
Updated August 2008 |
